EMA Validates Marketing Authorization Application for Henlius’ HANSIZHUANG (Serplulimab)
HANSIZHUANG (serplulimab) is the first anti-PD-1 mAb for the first-line treatment of small cell lung cancer (SCLC) The EC and the FDA previously granted Orphan Drug Designations (ODDs) for HANSIZHUANG in SCLC HANSIZHUANG is approved in China for microsatellite instability-high (MSI-H) solid tumours, squamous non-small cell lung cancer (sqNSCLC) and extensive-stage small cell lung cancer (ES-SCLC), benefiting more...
Clarivate Announces Gordon Samson as President, Intellectual Property and Nominates Dr. Saurabh Saha as New Independent Director
Naming the first of three business leaders for its newly created market segments and nominating new Independent Director to its Board LONDON, March 24, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Gordon Samson, currently Chief...
Picarro and LESNI Partner to Deliver Comprehensive Ethylene Oxide Monitoring Solutions to Sterilization Facilities Worldwide
Combination of LESNI's abatement systems expertise and Picarro's advanced monitoring and data analytics technology will enable improvements in industrial emissions control SANTA CLARA, Calif., March 23, 2023 /PRNewswire/ -- Picarro, Inc. and LESNI A/S today announced a strategic partnership aimed at delivering industry-leading Ethylene Oxide (EtO or EO) monitoring solutions to medical device and contract sterilization facilities around the...
Clear Medical Imaging and See-Mode Technologies Announce Partnership via CureLabs Innovation Hub
MELBOURNE, Australia, March 23, 2023 /PRNewswire/ -- Clear Medical Imaging, a leading provider of radiology services and the second largest independent healthcare provider in Ontario, announces partnership with See-Mode Technologies to adopt See-Mode, an artificial intelligence (AI) software application that increases efficiencies within the ultrasound workflow by assessing ultrasound images, automatically detecting clinical pathologies, and building a complete report....
Northumbria Healthcare NHSFT and C-POLAR Technologies combine innovation in widely acclaimed hub
This partnership will create infection-resilient environments as C-POLAR captures, inactivates, and eradicates up to 99.99% of viruses, bacteria, and fungi HONG KONG, March 23, 2023 /PRNewswire/ -- C-POLAR Technologies, Inc., an international bioprotection leader offering revolutionary protection against viruses, bacteria, molds, fungi, and pollens, and its wholly owned subsidiary, C-POLAR Ireland Ltd., announced today that they have established a UK...
AnPac Bio-Medical Science Granted Continued Listing by NASDAQ Hearing Panel, Subject to Meeting the Equity Rule on or before July 12, 2023
NEW YORK, March 23, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food products, announced that on March...
Global Heart Hub and the Global Coalition on Aging launch a Global Position Paper on Heart Valve Disease (HVD) and the Healthy Aging Agenda
NEW YORK, March 23, 2023 /PRNewswire/ -- The Global Coalition on Aging (GCOA) and the Global Heart Hub (GHH) have released the global position paper "Heart Valve Disease: Harnessing Innovation to Save Lives, Mitigate Costs, and Advance the Healthy Aging Agenda", which builds on a December 2022 roundtable of cross-sector experts and examines how behavior and policy change can...
Everest Medicines Announces Signing of an MOU for Strategic Cooperation with Guangdong Academy of Medical Sciences in Renal Diseases
GUANGZHOU, China, March 23, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that it has signed an MOU for comprehensive strategic cooperation with Guangdong Academy of Medical Sciences in renal disease research, scientific innovation and translational studies. The signing...
JINGHAO Partners with Fosun Trade for Hearing Aids in the Global Area
BANGKOK, March 23, 2023 /PRNewswire/ -- Jinghao Medical (JINGHAO), an emerging and disruptive leading company in the filed of hearing aid solutions, is pleased to announce the signing of a cooperation agreement with Fosun Trade. The signing ceremony was held on March 3rd in Thailand and the senior executives and representatives of both companies attended the meeting. The cooperation agreement...
111, Inc. Announces Fourth Quarter and Fiscal Year 2022 Financial Results
SHANGHAI, March 23, 2023 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2022. Fourth Quarter 2022 Highlights Net revenues were RMB4.1 billion (US$601.4 million),...
